Specialized biosamples Dx Biosamples specializes in procuring diseased and normal fresh and preserved biospecimens across a wide range of disease targets, with accompanying comprehensive clinical data and pathology reports, enabling target-specific research collaborations and enabling pharma/biotech teams to access relevant materials efficiently.

IRB network growth The company is expanding an IRB approved network of specialty clinical sites with large patient populations, which can shorten sourcing timelines and improve access to diverse specimen cohorts for oncology, autoimmune, metabolic, neurology and other therapeutic areas.

Diverse biospecimen types Offerings include blood products, tissues (fresh, frozen, FFPE), serum, plasma, urine and other biofluids, enabling end-to-end sample sourcing for preclinical and translational studies across multiple modalities.

Data-enabled value All materials are accompanied by comprehensive clinical data and pathology reports, providing richer context for biomarker discovery, stratification, and correlated analyses useful for companion diagnostics and CRO projects.

Growth potential With revenue in the lower-mid range and a lean team, there is potential for scalable partnerships with larger contract research organizations and diagnostic companies seeking specialized, timely access to diverse specimen inventories.